Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. D Other Notice of Sales of Unregistered Securities
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. SCHEDULE 13D Stake Beneficial Ownership Report
  6. 3 Insider Initial Statement of Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  9. 10-Q Report Quarterly Report
  10. SCHEDULE 13D/A Stake Beneficial Ownership Report
  11. SCHEDULE 13D/A Stake Beneficial Ownership Report
  12. 10-Q Report Quarterly Report
  13. 4 Open-market sale Chief Executive Officer sold 735 shares at $3.38 ($2,484)
  14. 4 Open-market sale General Counsel sold 260 shares at $3.39 ($881)
  15. 4 Open-market sale Interim CFO sold 147 shares at $3.39 ($498)
  16. 8-K Event Shareholder vote results
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 18 · 353 filings